Thrive Capital: Q3 2026 13F
Josh Kushner’s venture firm.
Holdings as of Sep 30, 2026 (Q3 2026)Filed Nov 12, 202613F deadline Nov 16, 2026 (45 days after quarter end)
Portfolio at a glance
Largest stock and ETF positions sized by weight, coloured by change since the previous 13F.
Biggest moves
Estimated dollars bought and sold in Q3 2026 (change in shares × quarter-end price).
Top buys
Ranked by estimated dollars added: change in shares × quarter-end price.
| Stock | Change | Est. $ |
|---|---|---|
Space Exploration Techn Corp | Added+147.8% | +$4.2B |
OSCR 7.25 12.31.31 Oscar Health Inc | New | +$132M |
SECZ Securitize Corp | New | +$25M |
Top sales
Ranked by estimated dollars sold, including full exits.
| Stock | Change | Est. $ |
|---|---|---|
Oscar Health Inc | Sold out | −$181M |
New positions
| Stock | Change | Est. $ |
|---|---|---|
OSCR 7.25 12.31.31 Oscar Health Inc | New | +$132M |
SECZ Securitize Corp | New | +$25M |
Sold out
| Stock | Change | Est. $ |
|---|---|---|
Oscar Health Inc | Sold out | −$181M |
Largest holdings
Top 6 of 6 stock and ETF positions, as of Sep 30, 2026. Options are listed separately below.
Source: Thrive Capital Management, LLC, Form 13F-HR on SEC EDGAR, compared with the filing for Jun 30, 2026. 13F shows only US-listed long positions (plus listed options), is delayed up to 45 days, and estimated dollar changes assume the quarter-end price. Not investment advice. How we calculate this.